In a large international Phase II trial of 698 adults with biopsy-confirmed MASH and moderate-to-advanced fibrosis, including patients with compensated cirrhosis, semaglutide demonstrated a statistically significant improvement in liver fibrosis without worsening MASH, even in those with more advanced disease
Clin Cancer Res (2013) 19(24):674150
Anthem wants to see progress notes from your healthcare provider documenting specific dietary counseling, caloric goals, physical activity recommendations, and follow-up assessments showing that lifestyle changes alone were insufficient
All treatments are administered by licensed medical professionals in a sterile environment
Goday A, Bellido D, Sajoux I, Crujeiras AB, Burguera B, Garca-Luna PP, et al